$ Value
$0
Shares
327,262
Price
$0
Filed
Apr 17
Insider
Name
Coulie Bernard
Title
President and CEO
CIK
0001808895
Roles
Transaction Details
Transaction Date
2026-04-17
Code
D
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
On April 15, 2026, the Issuer's board of directors approved an option repricing (the "Repricing"), effective April 17, 2026 (the "Effective Date"), for all stock options granted on or before March 1, 2025 to the Issuer's current employees, including the Reporting Person. All of the other terms of the options remain unchanged. | The stock option award was issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the "2015 Plan"), or the Issuer's 2020 Stock Option and Incentive Plan, as amended (the "2020 Plan"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on the Reporting Person's applicable Form 3 or Form 4, subject to the Reporting Person's continued service to the Issuer as of the applicable vesting dates. | The expiration date has been updated from the Form 3 originally filed on June 2, 2020 from January 23, 2029 to the correct expiration date of January 24, 2029. | The closing price per share of the Issuer's common stock on the Effective Date. Under the terms of the Repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The "Retention Period" commenced on the Effective Date and ends on the earliest of the following: (i) the eighteen-month anniversary of the Effective Date; (ii) the consummation of a Corporate Transaction (as defined by the 2015 Plan) or a Sale Event (as defined by the 2020 Plan); and (iii) the Reporting Person's (a) termination without cause (as defined in the Reporting Person's severance plan) or due to a reduction in force, (b) death or termination due to disability, or (c) resignation from service for good reason (as defined in the Reporting Person's severance plan). | The repriced options will also revert to its original exercise price if the Reporting Person (i) is terminated for cause (as defined in the Reporting Person's severance plan) or (ii) resigns prior to the end of the Retention Period, except for good reason (as defined in the Reporting Person's severance plan). | The expiration date has been updated from the Form 3 originally filed on June 2, 2020 from March 30, 2030 to the correct expiration date of March 31, 2030. | The expiration date has been updated from the Form 4 originally filed on January 26, 2021 from January 22, 2031 to the correct expiration date of January 23, 2031. | The expiration date has been updated from the Form 4 originally filed on February 2, 2022 from January 25, 2032 to the correct expiration date of January 26, 2032. | The expiration date has been updated from the Form 4 originally filed on January 27, 2023 from January 24, 2033 to the correct expiration date of January 25, 2033.
Filing Info
Coulie Bernard's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | PLRX | D | $0 |
| 2026-04-17 | PLRX | A | $0 |
| 2026-04-17 | PLRX | D | $0 |
| 2026-04-17 | PLRX | A | $0 |
| 2026-04-17 | PLRX | D | $0 |
| 2026-04-17 | PLRX | A | $0 |
| 2026-04-17 | PLRX | D | $0 |
| 2026-04-17 | PLRX | A | $0 |
| 2026-04-17 | PLRX | D | $0 |
| 2026-04-17 | PLRX | A | $0 |
Other Insiders at PLRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Coulie Bernard
President and CEO
|
— | — | 2026-04-17 |
|
Cummings Keith Lamont
Chief Financial Officer
|
— | — | 2026-04-17 |
|
Cheung Lily
Chief Human Resource Officer
|
— | — | 2026-04-17 |
|
Kuo Minnie
Chief Operating Officer
|
— | — | 2026-04-17 |